Glimepiride-Metformin Market Insights, Size and Growth Forecast To 2024

Published: Apr 2019	Report ID: PHAR1905	Pages: 1 - 95	Formats^*:
Category : Pharmaceutical

Report description

The market research report of Glimepiride/Metformin includes all integrated approach to growth of the market along with an elaborate & accurate analysis of the complete competitive situation of this market on a global level with the key market trends & newest technologies, being a major part in the growth during the estimated period. Besides the current analytical & statistical account, the report cloaks the trends market drivers, challenges, potential opportunities, which have an effect on the market. This market report discusses the present situation to predicted trends & aspects of the Glimepiride/Metformin market. Furthermore, it gives a dynamic overview & insights related to the market at both global as well as regional scale. “GLIMEPIRIDE/METFORMIN” is a combination drug containing Glimepiride & metformin. Glimepiride is a white to yellowish-white, crystalline, odorless to practically odorless powder formulated into tablets of 1-mg, 2-mg, and 4-mg strengths for oral administration. The global Glimepiride/Metformin market is forecast to witness growth from **** MTS (**** Million USD) to **** MTS (**** Million USD) with a CAGR of XX% for the session 2018-23. Metformin is first line medication used for treatment of diabetes & Glimepiride is second generation sulfonylurea antidiabetic drug, combination is a type of sulfonylurea anti diabetic medicine that helps the pancreas in releasing insulin thus helping reduce the blood sugar level. There are number of brands available for various strength combination, AMARYL-M (Glimepiride 1000 Mg /Metformin 500 Mg tablets) is an oral blood-glucose-lowering drug of the sulfonylurea class. Glimepiride/Metformin market after patent expiry in **** enhance in terms of volume from **** MTS (**** Million USD) to **** MTS (**** Million USD) with a CAGR of XX% for the session 2014-17

This report represents the global and regional analysis of "Glimepiride/Metformin" in terms of Dosage, Strength, API, application wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent wise (North America, Europe, Asia, South America, Africa & Oceania) manufacturer & consumer analysis & market share.

REPORT HIGHLIGHTS

Provide manufacturing capacity, consumption, current & past status & also the forecasting up to 2023.
Provide complete overview including type, application & forecast region.
Provide complete analysis of API & formulation including brand names, strength & market overview.
Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
Historical, current and projected market size in terms of volume and value.
Analyze the global & regional potential market, advantages, risk & opportunity.
Identify significant trends and factors driving or inhibiting market growth.
In-depth coverage of the complete market in terms of supplier, buyer, price, trend, growth & forecasting.

THE REPORT COVERS EXHAUSTIVE ANALYSIS ON

Market Segments
Market Dynamics
Brands in Market
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Forecasting
Technology

THE REPORT INCLUDES REGIONAL ANALYSIS ON

Asia-Pacific (China, India, South Korea, Taiwan & Rest of Asia Pacific Available)
Europe (Germany, Spain, France, United Kingdom & Rest of Europe Available
North America (Canada, United State, Mexico, Guatemala & Rest of North America Available)
South America (Paraguay, Bolivia, Peru Argentina & Rest of South America Available)
Middle East & Africa (GCC Countries, South Africa, Ghana, Egypt, North Africa & Rest of MEA Available)
Oceania & Australia

TOP PLAYERS IN GLIMEPIRIDE/METFORMIN INDUSTRY

Sanofi Aventis
IPCA Laboratories Ltd
Unicorn MSJ Ltd
Intas Pharmaceutical
Solrex Pharmaceutical Co.
**************************
**************************
**************************
**************************
**************************
***************************

KEY QUESTIONS ANSWERED BY REPORT

What was the market size trend of 2014-2017?
What will be the market size trend of the next 45 years?
What are the most common brands in terms of volume?
How many brands available for Glimepiride/Metformin?
Who are the key players of Glimepiride/Metformin?
What are the major application industries & emerging industries?
Who are the key vendors present in the market?
How future opportunities & market drivers will affect market dynamics & on-going trends?
Which one segment from global coverage will be lucrative & will grow?
What are the main market opportunities and threats faced by the vendors?
What are the strategies are following by the existing market players?

CHAPTER 1 RESEARCH METHODOLOGY

CHAPTER 2 REPORT DESCRIPTION

CHAPTER 3 GLIMEPIRIDE/METFORMIN EXECUTIVE SUMMARY

CHAPTER 4 GLIMEPIRIDE/METFORMIN BASIC HIGHLIGHTS

4.1. Glimepiride/Metformin Overview
4.2. Glimepiride/Metformin CAS No
4.3. Glimepiride/Metformin Molecular Weight
4.4. Glimepiride/Metformin Molecular Formula
4.5. Glimepiride/Metformin Originator
4.6. Glimepiride/Metformin Priority Date & Patent Expiry

CHAPTER 5 GLOBAL GLIMEPIRIDE/METFORMIN PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY

5.1. Glimepiride/Metformin Industry Segmentation
5.2. Glimepiride/Metformin Synonym
5.3. Glimepiride/Metformin Indication
5.4. Glimepiride/Metformin Route of Administration & Dosage

CHAPTER 6 GLIMEPIRIDE/METFORMIN MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM

6.1. Raw Material Required For Glimepiride/Metformin Manufacturing Process
6.2. Glimepiride/Metformin Manufacturing Process & Flow Diagram
6.3. Glimepiride/Metformin Chemical Reaction

CHAPTER 7 GLIMEPIRIDE/METFORMIN BRAND LIST & MECHANISM OF ACTION

7.1. Glimepiride/Metformin Brand List & Dosage with Strength
7.2. Glimepiride/Metformin Mechanism of Action

CHAPTER 8 GLIMEPIRIDE/METFORMIN REGION WISE MARKET OVERVIEW

8.1. Glimepiride/Metformin Market Overview In Asia-Pacific (China, India, South Korea, Taiwan & Rest of Asia Pacific Available)
8.2. Glimepiride/Metformin Market Overview In Europe (Germany, Spain, France, United Kingdom & Rest of Europe Available
8.3. Glimepiride/Metformin Market Overview In North America (Canada, US, Mexico, Guatemala & Rest of North America Available)
8.4. Glimepiride/Metformin Market Overview In South America (Paraguay, Bolivia, Peru Argentina & Rest of South America Available)
8.5. Glimepiride/Metformin Market Overview In Middle East & Africa (GCC Countries, South Africa, Ghana, Egypt, North Africa& Rest of MEA Available)
8.6. Glimepiride/Metformin Market Overview In Oceania & Australia

CHAPTER 9 GLIMEPIRIDE/METFORMIN CONTINENT & COUNTRY WISE COMPETITIVE LANDSCAPE ANALYSIS

9.1. Glimepiride/Metformin Global Manufacturer Overview
9.2. Glimepiride/Metformin Continent Wise Production Volume Analysis
9.3. Glimepiride/Metformin Country Wise Production Volume
9.4. Glimepiride/Metformin Top Player Analysis
9.5. Glimepiride/Metformin Continent Wise Market Share
9.6. Glimepiride/Metformin Manufacturers Deliverable Format

CHAPTER 10 GLIMEPIRIDE/METFORMIN & FORMULATION GLOBAL PRICE TREND ANALYSIS OF LAST 5 YEARS (2014-2018)

10.1 Glimepiride/Metformin Continent & Country Wise 2014 Price Range Analysis
10.2 Glimepiride/Metformin Continent & Country Wise 2015 Price Range Analysis
10.3 Glimepiride/Metformin Continent & Country Wise 2016 Price Range Analysis
10.4 Glimepiride/Metformin Continent & Country Wise 2017 Price Range Analysis
10.5 Glimepiride/Metformin Continent & Country Wise 2018 Price Range Analysis

CHAPTER 11 GLIMEPIRIDE/METFORMIN GLOBAL MARKET OVERVIEW

11.1. Global Demand/ Supply & Prices Analysis
11.2. Key Players Involved (Capacities & Prices)

CHAPTER 12 GLIMEPIRIDE/METFORMIN GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2018-2023) ANALYSIS

12.1. Glimepiride/Metformin Global Market Size & Market Growth In Terms of Volume (2014-17)
12.2. Glimepiride/Metformin Global Market Size & Market Growth In Terms of Value Million USD (2014-17)
12.3. Glimepiride/Metformin Global Market Size & Market Growth In Terms of Volume (2018-23)
12.4 Glimepiride/Metformin Global Market Size & Market Growth In Terms of Value Million USD (2018-23)

CHAPTER 13 GLIMEPIRIDE/METFORMIN CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW

13.1. Glimepiride/Metformin Global Consumer Overview
13.2. Glimepiride/Metformin Continent Wise Consumption Analysis
13.3 Glimepiride/Metformin Key Consumers
13.4. Glimepiride/Metformin Continent Wise Market Share
13.5. Glimepiride/Metformin List of Countries Involved in Consumption
13.6. Glimepiride/Metformin Consumer Deliverable Format

CHAPTER 14 GLIMEPIRIDE/METFORMIN REGULATORY INSIGHTS

14.1. Glimepiride/Metformin List of Patent Filed
14.2 Glimepiride/Metformin DMF Holders
14.3. Glimepiride/Metformin COS Filed
14.4. Glimepiride/Metformin SPC Filed
14.5. Glimepiride/Metformin Trial
14.6. Glimepiride/Metformin JDMF Filed
14.7. Glimepiride/Metformin EU Written Confirmation
14.8. Glimepiride/Metformin HS Code Wise Indian Custom Import Duty

CHAPTER 15 GLIMEPIRIDE/METFORMIN CONTINENT WISE EXPORTS/ IMPORT ANALYSIS

15.1. Global Glimepiride/Metformin Export Analysis (2017-18)
15.2 Global Glimepiride/Metformin Import Analysis (2017-18)
15.3. Global Glimepiride/Metformin Export-Import Analysis (2014-18)
15.4. Global Glimepiride/Metformin Continent Wise Export Analysis (2014-18)
15.5. Global Glimepiride/Metformin Continent Wise Import Analysis (2014-18)
15.6. Global Glimepiride/Metformin Country Wise Import Analysis (2014-18)
15.7. Global Glimepiride/Metformin Country Wise Export Analysis (2014-18)
15.8. Global Glimepiride/Metformin Importer Wise Import Analysis (2014-18)
15.9. Global Glimepiride/Metformin Exporter Wise Export Analysis (2014-18)

CHAPTER 16 GLIMEPIRIDE/METFORMIN WORLDWIDE SWOT ANALYSES

16.1. Glimepiride/Metformin Strength Analysis
16.2. Glimepiride/Metformin Weakness Analysis
16.3. Glimepiride/Metformin Opportunity Analysis
16.4. Glimepiride/Metformin Threat Analysis

CHAPTER 17 GLIMEPIRIDE/METFORMIN REPORT BASED BUSINESS RECOMMENDATION

LIST OF TABLES

Table 1: Route of Administration
Table 2: List of Manufacturing Equipment Required
Table 3: Raw Material Required for 100 KG Batch Glimepiride/Metformin Manufacturing
Table 4: Raw Material Required for Stage 2 Glimepiride/Metformin Manufacturing
Table 5: List of Global Brand with Strength & Dosage Type
Table 6: Glimepiride/Metformin Country Wise Asian Market Overview
Table 7: Glimepiride/Metformin Country Wise European Market Overview
Table 8: Glimepiride/Metformin Country Wise North American Market Overview
Table 9: Glimepiride/Metformin Country Wise South American Market Overview
Table 10: Glimepiride/Metformin Country Wise African Market Overview
Table 11: Glimepiride/Metformin Country Wise Australian Market Overview
Table 12: Glimepiride/Metformin Continent Wise Global Manufacturer Market Overview
Table 13: Glimepiride/Metformin Manufacturer Deliverable Format
Table 14: Glimepiride/Metformin Continent & Country Wise 2014 Price Range Analysis
Table 15: Glimepiride/Metformin Continent & Country Wise 2015 Price Range Analysis
Table 16: Glimepiride/Metformin Continent & Country Wise 2016 Price Range Analysis
Table 17: Glimepiride/Metformin Continent & Country Wise 2017 Price Range Analysis
Table 18: Glimepiride/Metformin Continent & Country Wise 2018 Price Range Analysis
Table 19: List of Key Manufacturer with Brand Name & Approximate Price
Table 20: Market Size in Terms of Volume (KG) Analysis (2014-17)
Table 21: Market Size in Terms of Million USD Analysis (2014-17)
Table 22: Market Size in Terms of Volume (KG) Analysis (2018-23)
Table 23: Market Size in Terms of Volume Million USD Analysis (2018-23)
Table 24: Global Glimepiride/Metformin Consumer Analysis
Table 25: Global Glimepiride/Metformin Consumer Deliverable Format
Table 26: Glimepiride/Metformin Patent Overview & Format
Table 27: Glimepiride/Metformin DMF Filed
Table 28: Glimepiride/Metformin COS Overview
Table 29: Glimepiride/Metformin SPC Filed
Table 30: Glimepiride/Metformin Trial List
Table 31: Glimepiride/Metformin List of JDMF Filed
Table 32: Glimepiride/Metformin EU Written Confirmation
Table 33: Glimepiride/Metformin Indian Custom Import Duty for HS Code 29XXXXX
Table 34: Glimepiride/Metformin Indian Custom Import Duty for HS Code 29XXXXX
Table 35: Glimepiride/Metformin Indian Custom Import Duty for HS Code 38XXXXX
Table 36: Global Glimepiride/Metformin Export Analysis (2017-18)
Table 37: Global Glimepiride/Metformin Import Analysis (2017-18)
Table 38: Global Glimepiride/Metformin Export-Import Analysis (2014-18)
Table 39: Global Glimepiride/Metformin Continent Wise Export Analysis (2014-18)
Table 40: Global Glimepiride/Metformin Continent Wise API Import Analysis (2014-18)
Table 41: Global Glimepiride/Metformin Country Wise API Import Analysis (2014-18)
Table 42: Global Glimepiride/Metformin Country Wise API Export Analysis (2014-18)
Table 43: Global Glimepiride/Metformin Importer Wise Import Analysis (2014-18)
Table 44: Global Glimepiride/Metformin Exporter Wise Export Analysis (2014-18)

LIST OF FIGURES

Figure 1: Continent Wise Market Share
Figure 2: Glimepiride/Metformin Structure
Figure 3: Glimepiride/Metformin Dosage Type
Figure 4: Glimepiride/Metformin Flow Chart
Figure 5: Glimepiride/Metformin Chemical Manufacturing Reaction
Figure 6: Glimepiride/Metformin Mechanism of Action
Figure 7: Glimepiride/Metformin Country Wise Asian Market Overview
Figure 8: Glimepiride/Metformin Country Wise European Market Overview
Figure 9: Glimepiride/Metformin Country Wise North American Market Overview
Figure 10: Glimepiride/Metformin Country Wise South American Market Overview
Figure 11: Glimepiride/Metformin Country Wise African Market Overview
Figure 12: Glimepiride/Metformin Continent Wise Global Manufacturer
Figure 13: Glimepiride/Metformin Continent Wise Manufacturer Production Volume
Figure 14: Glimepiride/Metformin Country Wise Manufacturer Production Volume
Figure 15: Glimepiride/Metformin Key Players
Figure 16: Continent Wise API Market Share Analysis
Figure 17: Global Demand Supply Overview Analysis
Figure 18: Global Continent Wise Glimepiride/Metformin No. of Consumers
Figure 19: Global Continent Wise Glimepiride/Metformin Consumption Volume
Figure 20: Global Continent Wise Glimepiride/Metformin Key Consumer Analysis
Figure 21: Global Continent Wise Consumer Market Share Overview
Figure 22: Global Country Wise Consumer Market Share Overview
Figure 23: Global Continent Wise API Export Overview
Figure 24: Global Continent Wise API Import Overview
Figure 25: Global Continent Wise API Export Import (2014-2018) Overview

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1